Point-of-care molecular diagnostics depends on more than a sensitive assay. It also requires a practical way to prepare and control a sample, amplify target genetic material, detect the result and deliver the process close to where care is provided. A platform developed by STMicroelectronics and diagnostic-instrument producer Alifax illustrates how semiconductor manufacturing and microfluidics can be combined to support that workflow.
The system, called Molecular Mouse, uses real-time polymerase chain reaction (PCR) to detect genetic material in patient samples. Its design pairs a portable instrument with a small disposable cartridge and assay-specific reagents. For industrial automation professionals, the platform is a useful example of how precise thermal control, sensing, electronics and high-volume manufacturing methods can be integrated into a compact diagnostic device.
How the point-of-care molecular diagnostics platform works
PCR amplifies selected genetic material so that a target can be detected when it is present in a sample. The Molecular Mouse performs quantitative real-time PCR, or qPCR, in reaction chambers within a disposable cartridge. The instrument manages heating and cooling cycles needed for amplification while monitoring fluorescence from reagents designed to identify a specific target.
For the COVID-19 test described by the companies, Alifax developed reagents with fluorescent tags. As the reaction proceeds, the instrument measures fluorescence intensity across multiple wavelengths. That signal is used to determine whether the target genetic material is present in each chamber. The described workflow uses two chambers per sample for the COVID-19 test.
The cartridge contains six small reaction chambers. Each chamber provides a controlled space for the sample and reagents, while the instrument supplies the thermal cycling and optical measurement functions. Results are available in less than an hour, according to the release. The cartridge is manufactured by ST using its high-volume MEMS semiconductor process technology.
Semiconductor manufacturing meets microfluidics
The platform draws on semiconductor production techniques to make a disposable component for a biological testing workflow. ST’s role includes manufacturing the cartridges and supplying electronic components used in the instrument. These include STM32 microcontrollers, sensors, amplifiers and other devices. The Molecular Mouse connects to a PC and uses Alifax-developed medical reagents to run tests.
This arrangement separates several functions across the system: the cartridge provides the reaction chambers, the reagents determine what genetic material the assay targets, and the instrument controls the test and detects the fluorescent response. For system designers, this illustrates why diagnostic equipment is a multidisciplinary engineering challenge. The mechanical and microfluidic design must work alongside thermal management, sensing, signal processing and assay chemistry.
ST says its work in microfluidics spans more than 25 years, and that it had developed MEMS-based real-time PCR technology for roughly a decade before this product generation. That manufacturing and development background enabled Alifax to adapt the platform for a COVID-19 assay. The underlying approach is also intended to be customizable: ST’s PCR technology can be adapted to detect different genetic material, while Alifax develops the corresponding pathogen-specific reagents.
Adaptable assays and a compact instrument
Assay flexibility matters because the instrument alone does not identify a pathogen. The test depends on reagents designed to recognize particular genetic targets. Alifax had been developing assay panels for sepsis and tests for Zika, Dengue and Chikungunya before reallocating resources to develop COVID-19 assays. The company indicated that the other assays would follow.
The instrument is designed for point-of-care use, with a footprint smaller than a smartphone. Its compact form factor is paired with a disposable cartridge smaller than a microscope slide. Rather than requiring the biological reaction to take place in a large, fixed laboratory instrument, the platform brings the PCR process into a portable system connected to a PC.
For operations and product teams, the architecture highlights a practical trade-off: a reusable instrument handles control and measurement, while a single-use cartridge contains the reaction chambers. Assay-specific reagents provide the biological recognition step. This modular arrangement supports adaptation of the test target without changing the basic concept of the instrument and cartridge workflow, although each assay still requires its own suitable reagents.
Engineering considerations for diagnostic systems
Developing a compact molecular diagnostic system requires coordination across several technical areas:
- Thermal control: Reaction chambers must support the heating and cooling required to amplify genetic material.
- Optical sensing: Fluorescence must be measured at multiple wavelengths to identify the assay signal.
- Electronics and control: Microcontrollers, sensors and amplifiers contribute to managing and reading the test process.
- Consumable manufacturing: The disposable cartridge must be produced with chambers suitable for the assay workflow.
- Assay development: Reagents must be tailored to detect the intended genetic target.
The release states that the Molecular Mouse, disposable cartridges and assays were CE-IVD certified under the European In-Vitro Diagnostic Medical Device Directive cited at the time. That regulatory context is part of the system’s deployment story: diagnostic hardware, consumables and assays must be considered together rather than as independent components.
What the platform means for automation and manufacturing
The Molecular Mouse shows how capabilities developed for semiconductor and MEMS production can be applied to diagnostic instrumentation. High-volume manufacturing methods, compact electronics and microfluidic cartridge design are brought together with PCR and assay chemistry. The result is a portable testing system intended to provide molecular results near the point of care, with the described test returning results in less than an hour.
For industrial automation engineers and technical decision-makers, the broader lesson is the importance of system integration. A compact diagnostic device depends on coordinated control of thermal, optical, electronic and consumable processes, as well as the ability to adapt assay content to new targets. In this case, the instrument platform and manufacturing approach support that adaptability, while assay-specific development determines what the system can detect. This combination offers a practical model for translating precision manufacturing technologies into specialized, portable diagnostic equipment.